# Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries

> **NCT06545890** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cairo University** · enrollment: 46 (estimated)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT06545890
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-10
- **Primary completion:** 2024-11-01
- **Final completion:** 2024-11-10
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545890, "Ketofol Versus Dexmedetomidine for Prevention of Emergence Delirium in Pediatric Patients Undergoing Squint Surgeries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06545890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*